Kanada - angielski - Health Canada

hospira healthcare ulc - acetyl-l-tyrosine; dextrose; sodium chloride; potassium chloride; magnesium chloride; calcium chloride; potassium phosphate dibasic; l-isoleucine; serine; l-leucine; lysine (lysine acetate); methionine; l-phenylalanine; l-threonine; tryptophan; l-valine; l-alanine; l-arginine; l-aspartic acid; glutamic acid; glycine; histidine; l-proline - solution - 115mg; 20g; 205mg; 22mg; 51mg; 37mg; 261mg; 280mg; 225mg; 425mg; 446mg; 73mg; 126mg; 170mg; 85mg; 212mg; 422mg; 432mg; 298mg; 314mg; 212mg; 128mg; 307mg - acetyl-l-tyrosine 115mg; dextrose 20g; sodium chloride 205mg; potassium chloride 22mg; magnesium chloride 51mg; calcium chloride 37mg; potassium phosphate dibasic 261mg; l-isoleucine 280mg; serine 225mg; l-leucine 425mg; lysine (lysine acetate) 446mg; methionine 73mg; l-phenylalanine 126mg; l-threonine 170mg; tryptophan 85mg; l-valine 212mg; l-alanine 422mg; l-arginine 432mg; l-aspartic acid 298mg; glutamic acid 314mg; glycine 212mg; histidine 128mg; l-proline 307mg - caloric agents

Kanada - angielski - Health Canada

pro doc limitee - quetiapine (quetiapine fumarate) - tablet - 25mg - quetiapine (quetiapine fumarate) 25mg - atypical antipsychotics

Kanada - angielski - Health Canada

pro doc limitee - quetiapine (quetiapine fumarate) - tablet - 100mg - quetiapine (quetiapine fumarate) 100mg - atypical antipsychotics

Kanada - angielski - Health Canada

pro doc limitee - quetiapine (quetiapine fumarate) - tablet - 200mg - quetiapine (quetiapine fumarate) 200mg - atypical antipsychotics

Kanada - angielski - Health Canada

pro doc limitee - quetiapine (quetiapine fumarate) - tablet - 300mg - quetiapine (quetiapine fumarate) 300mg - atypical antipsychotics

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

preferred pharmaceuticals inc. - atorvastatin calcium trihydrate (unii: 48a5m73z4q) (atorvastatin - unii:a0jwa85v8f) - atorvastatin 20 mg - therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. drug therapy is recommended as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. in patients with chd or multiple risk factors for chd, atorvastatin calcium tablets can be started simultaneously with diet. in adult patients without clinically evident coronary heart disease, but with multiple risk factors for coronary heart disease such as age, smoking, hypertension, low hdl-c, or a family history of early coronary heart disease, atorvastatin calcium tablets are indicated to: in adult patients with type 2 diabetes, and without clinically evident coronary heart disease, but with multiple risk factors for coronary heart disease such as retinopathy, albuminuria, smoking, or hypertension, atorvastatin

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

ncs healthcare of ky, inc dba vangard labs - atorvastatin calcium trihydrate (unii: 48a5m73z4q) (atorvastatin - unii:a0jwa85v8f) - atorvastatin 10 mg - therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. drug therapy is recommended as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. in patients with chd or multiple risk factors for chd, atorvastatin calcium tablets can be started simultaneously with diet. in adult patients without clinically evident coronary heart disease, but with multiple risk factors for coronary heart disease such as age, smoking, hypertension, low hdl-c, or a family history of early coronary heart disease, atorvastatin calcium tablets are indicated to:  - reduce the risk of myocardial infarction     - reduce the risk of stroke     - reduce the risk for revascularization procedures and angina in patients with type 2 diabetes, and without clinically evident coronary heart dise

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

st marys medical park pharmacy - atorvastatin calcium trihydrate (unii: 48a5m73z4q) (atorvastatin - unii:a0jwa85v8f) - atorvastatin 10 mg - therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. drug therapy is recommended as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. in patients with chd or multiple risk factors for chd, atorvastatin calcium tablets can be started simultaneously with diet. in adult patients without clinically evident coronary heart disease, but with multiple risk factors for coronary heart disease such as age, smoking, hypertension, low hdl-c, or a family history of early coronary heart disease, atorvastatin calcium tablets are indicated to: - reduce the risk of myocardial infarction - reduce the risk of stroke - reduce the risk for revascularization procedures and angina in patients with type 2 diabetes, and without clinically evident coronary heart disease, but

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

preferred pharmaceuticals inc. - atorvastatin calcium trihydrate (unii: 48a5m73z4q) (atorvastatin - unii:a0jwa85v8f) - atorvastatin 20 mg - therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. drug therapy is recommended as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. in patients with chd or multiple risk factors for chd, atorvastatin calcium tablets can be started simultaneously with diet. in adult patients without clinically evident coronary heart disease, but with multiple risk factors for coronary heart disease such as age, smoking, hypertension, low hdl-c, or a family history of early coronary heart disease, atorvastatin calcium tablets are indicated to:  in patients with type 2 diabetes, and without clinically evident coronary heart disease, but with multiple risk factors for coronary heart disease such as retinopathy, albuminuria, smoking, or hypertension, atorvastatin calci

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

preferred pharmaceuticals, inc. - atorvastatin calcium trihydrate (unii: 48a5m73z4q) (atorvastatin - unii:a0jwa85v8f) - atorvastatin 80 mg - therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. drug therapy is recommended as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. in patients with chd or multiple risk factors for chd, atorvastatin calcium tablets can be started simultaneously with diet. in adult patients without clinically evident coronary heart disease, but with multiple risk factors for coronary heart disease such as age, smoking, hypertension, low hdl-c, or a family history of early coronary heart disease, atorvastatin calcium tablets are indicated to:  in patients with type 2 diabetes, and without clinically evident coronary heart disease, but with multiple risk factors for coronary heart disease such as retinopathy, albuminuria, smoking, or hypertension, atorvastatin calci